Rani Therapeutics Holdings, Inc.
RANINASDAQHealthcareBiotechnology
As of Oct 23, 2026 close
- Market cap
- $113.41M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $0.61$3.87
- Volume (live)
- -
- Avg. volume (3M)
- 589.39K
Rani Therapeutics Holdings (RANI) Stock Price & Financial Analysis
Rani Therapeutics Holdings Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $0.59 - $0.61 |
|---|---|
| 52-Week High | $3.87 |
| 52-Week Low | $0.61 |
| Open | $0.60 |
| Volume (last close) | 290.76K |
| Average Volume (3M) | 589.39K |
| Revenue (TTM) | 4.88M |
|---|---|
| Net Income (TTM) | -30.14M |
| Free Cash Flow (TTM) | -20.34M |
| EPS (TTM) | −$0.22 |
| Profit Margin | -618.02% |
| Operating Margin | -675.80% |
| Return on Equity (ROE) | -76.82% |
| Debt to Equity | 0.09 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Market Cap | 113.41M |
|---|---|
| Shares Outstanding | 187.17M |
| Price to Sales (P/S) | 23.25 |
| Price to Book (P/B) | 2.89 |
| EV/EBITDA | -3.40 |
| 50-Day MA | $0.80 |
|---|---|
| 200-Day MA | $0.96 |
| 1-Year Change | −71.89% |
Source: Market prices and company fundamentals. Data as of Oct 23, 2026. Data sources and methodology
Rani Therapeutics Holdings at a Glance
As of the Oct 23, 2026 close, Rani Therapeutics Holdings (RANI) has a market capitalization of $113.41M. The stock trades at 23.3× sales. Over the trailing twelve months it lost $30.14M on revenue of $4.88M and burned $20.34M of free cash flow. Revenue grew 118.9% year over year.
As of its latest reported balance sheet, it holds $4.87M in cash and securities against $3.55M of debt, a net cash position of $1.32M.
Rani Therapeutics Holdings does not currently pay a dividend.
The share price is down 71.9% over the past year. At $0.61 (the Oct 23, 2026 close) it sits near the bottom of its 52-week range of $0.61 to $3.87, below its 200-day moving average of $0.96.
Based on 4 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $6.75, 1014.0% above the Oct 23, 2026 close.
Frequently Asked Questions About Rani Therapeutics Holdings
What is the current stock price for RANI?
As of the Oct 23, 2026 close, RANI stock trades at $0.61. The 52-week range is $0.61–$3.87, with a day range of $0.59–$0.61.
What is the P/E ratio for RANI?
The P/E ratio (Price-to-Earnings) for RANI is shown in the Key Statistics section. This valuation metric helps compare Rani Therapeutics Holdings, Inc. to industry peers.
Does RANI pay dividends?
Rani Therapeutics Holdings does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for RANI?
Based on ratings from 4 professional analysts over the last 90 days, the consensus for RANI is Buy. The average 12-month price target is $6.75, a 1014.0% upside from the Oct 23, 2026 close of $0.61.
What is the market cap of RANI?
As of the Oct 23, 2026 close, Rani Therapeutics Holdings's market capitalization is $113.4M, classifying it as a micro-cap company. Rani Therapeutics Holdings operates in the Healthcare sector within the Biotechnology industry.